Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China · Delayed Price · Currency is CNY 12.41
+0.11 (0.89%)
Jun 12, 2026, 3:04 PM CST
SHE:002020 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 759.89 | 757.98 | 711.96 | 618.9 | 662.25 | 612.54 |
Depreciation & Amortization | 281.14 | 281.14 | 295.28 | 219.95 | 166.87 | 149.92 |
Other Amortization | 21.56 | 21.56 | 15.49 | 11.55 | 33.08 | 32.6 |
Loss (Gain) From Sale of Assets | 0.57 | 0.57 | -2.59 | -6.86 | -0.61 | 0.48 |
Asset Writedown & Restructuring Costs | 15.69 | 15.69 | 0.07 | 0.01 | 0.07 | 8.42 |
Loss (Gain) From Sale of Investments | -26.58 | -26.58 | 33.41 | -30.88 | -29.57 | -55.39 |
Provision & Write-off of Bad Debts | 6.16 | 6.16 | 13.16 | 6.73 | 3.64 | 10.8 |
Other Operating Activities | 23.9 | 6.84 | 26.2 | 15.63 | -1.3 | 22.77 |
Change in Accounts Receivable | -26.57 | -26.57 | -249.65 | -93.48 | -250.89 | -208.58 |
Change in Inventory | -5.23 | -5.23 | -152.84 | 123.04 | -102.95 | -152.51 |
Change in Accounts Payable | -258.73 | -258.73 | 52.3 | -74.58 | 387.41 | -41.84 |
Change in Other Net Operating Assets | -0.44 | -0.44 | - | - | - | - |
Operating Cash Flow | 800.31 | 781.35 | 726.16 | 792.84 | 855.78 | 373.46 |
Operating Cash Flow Growth | 49.44% | 7.60% | -8.41% | -7.36% | 129.15% | -27.23% |
Capital Expenditures | -187.94 | -202.85 | -250.65 | -519.51 | -515.57 | -406.83 |
Sale of Property, Plant & Equipment | 4.09 | 3.89 | 5.2 | 10.27 | 1.99 | 2.93 |
Investment in Securities | -257.46 | 538.91 | -1,240 | -260.2 | -342.4 | 508.33 |
Other Investing Activities | 42.26 | 27.16 | 47.86 | 31.85 | 118.32 | 37.86 |
Investing Cash Flow | -399.06 | 367.11 | -1,438 | -737.59 | -737.66 | 142.29 |
Long-Term Debt Issued | - | 566.98 | 738.29 | 585 | 236.54 | 146.16 |
Total Debt Issued | 477.62 | 566.98 | 738.29 | 585 | 236.54 | 146.16 |
Long-Term Debt Repaid | - | -584.06 | -757.56 | -568.33 | -166.05 | -320.64 |
Total Debt Repaid | -472.06 | -584.06 | -757.56 | -568.33 | -166.05 | -320.64 |
Net Debt Issued (Repaid) | 5.57 | -17.08 | -19.27 | 16.67 | 70.49 | -174.48 |
Issuance of Common Stock | - | - | - | - | - | 515.56 |
Repurchase of Common Stock | -608.78 | -608.78 | - | - | - | - |
Common Dividends Paid | -284.85 | -284.85 | -258.31 | -258.31 | -258.56 | -232.17 |
Other Financing Activities | 513.57 | -5.03 | -2.58 | -3.97 | 0.04 | 4.47 |
Financing Cash Flow | -374.5 | -915.75 | -280.16 | -245.61 | -188.03 | 113.38 |
Foreign Exchange Rate Adjustments | -17.65 | -7.22 | 2.99 | 2.71 | 14.87 | -3.75 |
Net Cash Flow | 9.1 | 225.49 | -988.87 | -187.65 | -55.05 | 625.38 |
Free Cash Flow | 612.37 | 578.5 | 475.52 | 273.32 | 340.2 | -33.37 |
Free Cash Flow Growth | 136.23% | 21.66% | 73.98% | -19.66% | - | - |
Free Cash Flow Margin | 15.17% | 14.22% | 11.43% | 6.83% | 9.00% | -0.96% |
Free Cash Flow Per Share | 0.74 | 0.70 | 0.55 | 0.32 | 0.40 | -0.04 |
Cash Income Tax Paid | 365.26 | 306.67 | 260.88 | 245.5 | 262.09 | 231.14 |
Levered Free Cash Flow | - | -335.72 | 539.05 | -85.08 | 312.3 | -204.19 |
Unlevered Free Cash Flow | - | -333.24 | 543.89 | -80.51 | 316.06 | -201.08 |
Change in Working Capital | -282.02 | -282.02 | -366.83 | -42.18 | 21.35 | -408.69 |